LP
SANA icon

LMR Partners’s Sana Biotechnology SANA Stock Holding History

LMR Partners’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-130,000
Closed -$212K – 1605
2024
Q4 		$212K Sell
130,000
-220,000
-63% -$656K ﹤0.01% 948
2024
Q3 		$1.46M Buy
350,000
+273,500
+358% +$1.44M 0.01% 677
2024
Q2 		$418K Buy
+76,500
New +$610K ﹤0.01% 791

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

LMR Partners's SANA Position: Q4 2025 in Review

LMR Partners sold out of Sana Biotechnology (SANA) in Q4 2025, closing a stake of 242,553 shares — an estimated $861K sold.

LMR Partners first reported a position in SANA in Q2 2022 and held it in 4 quarters. The position peaked at $1.93M in Q2 2022. 203 funds tracked by Wall St. Rank hold SANA as of Q4 2025.

  • LMR Partners reported no remaining Sana Biotechnology position as of Q4 2025 after selling out during the quarter.
  • LMR Partners sold 242,553 Sana Biotechnology shares in Q4 2025, an estimated $861K.
  • LMR Partners first reported a position in Sana Biotechnology in Q2 2022 and held it in 4 quarters.
  • LMR Partners's Sana Biotechnology position peaked at $1.93M in Q2 2022.
  • 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2025.

Based on LMR Partners's 13F filing for Q4 2025, filed 17 Feb 2026.